Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neuro-Oncology is Scopus-indexed (Q1, CiteScore 21.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 1522-8517Verify ISSN ↗1523-5866Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: About US$5,132 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 7 / 403 | 98th | Q1 |
| Oncology | 18 / 428 | 95th | Q1 |
| Cancer Research | 14 / 233 | 94th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q1, CiteScore 21.1.
Neuro-Oncology is Q1 in Neurology (clinical) (rank 7 of 403), Q1 in Oncology (rank 18 of 428) and Q1 in Cancer Research (rank 14 of 233), by CiteScore 2025.
Neuro-Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 21.1, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 5.249, quartile Q1, with an H-index of 189.
The publisher lists an article processing charge of about US$5,132 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neuro-Oncology is published by Oxford University Press. Its print ISSN is 1522-8517 and its online ISSN is 1523-5866.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Neuro-Oncology has an h-index of 218 and a 2-year mean of 1.16 citations per paper (OpenAlex). Its Scopus CiteScore is 21.1, quartile Q1. On 2-year citations it ranks #245 of 403 Scopus journals in Neurology (clinical).
Neuro-Oncology published 2,986 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from United Kingdom (53.5%), United States (16.1%) and China (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 13 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.